Speciality: Radiation Oncology

Sub Specialities:

  • Lung Cancer
  • Biography

    Professor Gerry Hanna is a Professorial Fellow and the Marie Curie Chair of Clinical Oncology at Trinity College Dublin and a Consultant in Radiation Oncology at the St Lukes Radiation Oncology Network within the Trinity St James Cancer Institute. Gerry also holds honorary appointments at the University of Melbourne, and Queen’s University Belfast.

    His Research interests include the use of PET/CT in radiotherapy planning for lung cancer, mechanisms of radiotherapy resistance, stereotactic ablative radiotherapy and systemic therapy and immunotherapy combinations with radiotherapy.

    Prof Hanna is the Vice-Clinical Lead of Cancer Trials Ireland, Chief Investigator of the Peter Mac ACRF Radiation Immuno-oncology Program and the International Atomic Energy Agency’s “PERTAIN” study. Gerry leads the new formed All-Ireland Translational Radiation Oncology Network (AITRON). He is the former chief investigator and current TMG member of the CRUK funded CONCORDE study. Gerry is also a TMG member for the UK’s HALT, SARON, CONFIRM and ISOTOXIC IMRT studies.

  • Research / Publications
    1. Ashraf S, Khan M, Naguib N, Rulach R, Welsh K, Carozzi R, Horne A, Payne A, Bowen Jones S, Denholm M, Stewart G, Bedair A, Lindsay CR, Harrow S, Faivre-Finn C, McAleese J, Hanna GG, Hackshaw A, McDonald F, Walls GM. Should Radiation Dose Be Personalized in Patients With Localized NSCLC and Actionable Genetic Alterations? Insight From a Multicenter Real-World Study. JTO Clinical and Research Reports April 2025, Vol. 6 No. 4: 100774. https://doi.org/10.1016/j.jtocrr.2024.100774
    2. Hill N, Hanna GG, Walls GM, McAleese J. In Reply to Craig et al. JTO Clin Res Rep. 2024 Oct 16;5(12):100739. doi: 10.1016/j.jtocrr.2024.100739.
    3. Walls GM, Mitchell JD, Lyon AR, Harbinson M, Hanna GG. Radiation Oncology Opinions and Practice on Cardiotoxicity in Lung Cancer: A Cross-sectional Study by the International Cardio-oncology Society. Clin Oncol (R Coll Radiol). 2024 Sep 10:S0936-6555(24)00379-0. doi: 10.1016/j.clon.2024.09.001.
    4. Dunne VL, Ghita-Pettigrew M, Redmond KM, Small DM, Weldon S, Taggart CC, Prise KM, Hanna GG, Butterworth KT. PTEN Depletion Increases Radiosensitivity in Response to Ataxia Telangiectasia-Related-3 (ATR) Inhibition in Non-Small Cell Lung Cancer (NSCLC). Int J Mol Sci. 2024 Jul 17;25(14):7817. doi: 10.3390/ijms25147817.
    5. Walls GM, Hill N, McMahon M, Kearney B, McCann C, Kavanagh P, Giacometti V, Cole AJ, Jain S, McGarry CK, Butterworth K, McAleese J, Harbinson M, Hanna GG. Baseline Cardiac Parameters as Biomarkers of Radiation Cardiotoxicity in Lung Cancer, An NI-HEART Analysis. JACC CardioOncol. 2024 Jul 2;6(4):529-540.. https://doi.org/10.1016/j.jaccao.2024.05.009

    For a bibliography please see Professor Gerry Hanna’s TCD profile.

  • Professional Bodies
    • Fellow Trinity College Dublin
    • Fellow of the Royal College of Radiologists of London.
    • Honorary Fellow of the Faculty of Radiology of Radiology and Radiation Oncology, Royal College of Surgeons of Ireland.
    • Fellow of the Ulster Medical Society.
    • Supporting Ambassador of the European Society for Therapeutic Radiology and Oncology (ESTRO).
    • Founding Board Member of the Thoracic Oncology Group of Australasia.
    • Member of the Royal College of Physicians of London.
    • Member of the British Medical Association.
    • Member of American Society for Therapeutic Radiology and Oncology (ASTRO).
    • Vice-Clinical Lead Cancer Trials Ireland (All-Ireland Cooperative Oncology Research Group) and Lung Cancer DSSG Co-Chair.
    • Member of British Thoracic Oncology Group (BTOG).
    • Member of International Society for the Study of Lung Cancer (IASLC).
    • Member of ESTRO Lung Focus Group 2024-2027